- Serum Hemoglobin Levels Predict Response to Strontium-89 and Rhenium-186-HEDP Radionuclide Treatment for Painful Osseous Metastases in Prostate Cancer. van der Poel, H.G., Antonini, N., Hoefnagel, C.A., Horenblas, S., Valdes Olmos, R.A. Urologia internationalis. (2006)